跳至主要内容
临床试验/NCT06661902
NCT06661902已完成1 期

BURN Study: Buffered Lidocaine in Reducing Pain From Prostate Biopsy

University of Washington1 个研究点 分布在 1 个国家目标入组 350 人开始时间: 2025年1月9日最近更新:
适应症
干预措施

试验速览

阶段
1 期
状态
已完成
入组人数
350
试验地点
1
主要终点
Pain of Local Anesthetic Injection

研究概览

简要总结

This phase I/II trial examines if buffered lidocaine reduces the pain that patients may experience during prostate biopsy. Prostate biopsies are typically performed awake, in the office, with only local anesthetic. As a result, many patients note considerable pain during these procedures. Local anesthetics such as lidocaine are typically acidic, which is thought to cause pain and burning during infiltration (injection). As a result, buffered local anesthetic has become the standard of care (SOC) in multiple specialties using awake local anesthetic. However, it has not been explored during prostate biopsies. Adminstering buffered lidocaine may reduce pain in patients undergoing prostate biopsy.

详细描述

OUTLINE: Patients are randomized to 1 of 2 arms.

ARM A: Patients receive SOC lidocaine via injection during SOC prostate biopsy on study.

ARM B: Patients receive buffered lidocaine via injection during SOC prostate biopsy on study.

After completion of study intervention, patients are followed up 1-2 days post-biopsy.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

盲法说明

The Investigational Drug Services team will be unblinded to the patient's randomization status. During statistical analysis of the data, the statistician will be concealed to the randomization allocation.

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Male
接受健康志愿者

入选标准

  • Provision of signed and dated informed consent form
  • 18 years old or older
  • Patients with prostates
  • Those with and without a prior diagnosis of prostate cancer
  • Recommended to undergo a prostate biopsy in the urology clinic. Only patients that have been scheduled for a biopsy (for clinical purposes) will be enrolled. May include all of the following types of prostate biopsies:
  • Transperineal or transrectal
  • Systematic or targeted/fusion biopsy
  • 12 core biopsy or > 12cores
  • Biopsy naïve or prior biopsy

排除标准

  • Anorectal pathology precluding placement of a transrectal ultrasound
  • Diagnosis of chronic prostatitis, interstitial cystitis, pelvic pain syndrome
  • Concomitant chronic pain condition
  • Neurological condition affecting pain or sensorium (ex. spinal cord injury, stroke, multiple sclerosis, etc.)
  • Prostate biopsy performed with any anesthesia other than local anesthetic (monitored anesthesia care, general anesthesia)
  • Prostate biopsy completed in the operating room
  • Patients who ultimately require additional local anesthetic beyond what is allotted in the study intervention
  • Patients taking anxiolytics in the 6-hours prior to the biopsy
  • Those with a known hypersensitivity, allergic reaction, or contraindication to using sodium bicarbonate. This includes patients who are receiving diuretics known to produce a hypochloremic alkalosis

研究组 & 干预措施

Arm A (lidocaine)

Active Comparator

Patients receive SOC lidocaine via injection during SOC prostate biopsy on study.

干预措施: Lidocaine (Drug)

Arm A (lidocaine)

Active Comparator

Patients receive SOC lidocaine via injection during SOC prostate biopsy on study.

干预措施: Biopsy of Prostate (Procedure)

Arm A (lidocaine)

Active Comparator

Patients receive SOC lidocaine via injection during SOC prostate biopsy on study.

干预措施: Questionnaire Administration (Other)

Arm B (buffered lidocaine)

Experimental

Patients receive buffered lidocaine via injection during SOC prostate biopsy on study. (1% Lidocaine + 8.4% Sodium Bicarbonate, in a 3:1 ratio)

干预措施: Biopsy of Prostate (Procedure)

Arm B (buffered lidocaine)

Experimental

Patients receive buffered lidocaine via injection during SOC prostate biopsy on study. (1% Lidocaine + 8.4% Sodium Bicarbonate, in a 3:1 ratio)

干预措施: Questionnaire Administration (Other)

Arm B (buffered lidocaine)

Experimental

Patients receive buffered lidocaine via injection during SOC prostate biopsy on study. (1% Lidocaine + 8.4% Sodium Bicarbonate, in a 3:1 ratio)

干预措施: Buffered Lidocaine (1% Lidocaine + 8.4% Sodium Bicarbonate, in a 3:1 ratio) (Drug)

结局指标

主要结局

Pain of Local Anesthetic Injection

时间窗: Within 20 seconds of completing the injection of all local anesthetic

Pain associated with the injection of local anesthetic, assessed by a written questionnaire (Visual Analogue Scale, 0 \[least\] to 10 \[worst pain\]).

次要结局

  • Pain of the Prostate Biopsy(Within 10 minutes of completing the prostate biopsy, and on post-operative day 1)
  • Willingness to perform another prostate biopsy in the future, if medically necessary(Within 10 minutes of completing the prostate biopsy, and on post-operative day 1)
  • Incidence of adverse events(Post-operative day 1)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验